Search Results - "GREINER, Timothy"
-
1
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
Published in Blood (20-02-2014)“…The assignment of diffuse large B-cell lymphoma into cell-of-origin (COO) groups is becoming increasingly important with the emergence of novel therapies that…”
Get full text
Journal Article -
2
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
Published in Blood (11-04-2019)“…Peripheral T-cell lymphoma (PTCL) is a group of complex clinicopathological entities, often associated with an aggressive clinical course. Angioimmunoblastic…”
Get full text
Journal Article -
3
Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
Published in Blood (12-12-2019)“…Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of mature T-cell malignancies; approximately one-third of cases are designated as PTCL–not otherwise…”
Get full text
Journal Article -
4
Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
Published in Journal of clinical oncology (10-01-2011)“…Patients with diffuse large B-cell lymphoma (DLBCL) can be divided into prognostic groups based on the cell of origin of the tumor as determined by microarray…”
Get full text
Journal Article -
5
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Published in Blood (10-10-2013)“…Richter syndrome (RS) occurs in up to 15% of patients with chronic lymphocytic leukemia (CLL). Although RS, usually represented by the histologic…”
Get full text
Journal Article -
6
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Published in Blood (08-05-2014)“…Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms with generally poor clinical outcome. Currently 50% of PTCL cases are not…”
Get full text
Journal Article -
7
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma
Published in Blood (21-03-2019)“…Although generally curable with intensive chemotherapy in resource-rich settings, Burkitt lymphoma (BL) remains a deadly disease in older patients and in…”
Get full text
Journal Article -
8
Transitioning From T-Cell Clonality Testing to High-Throughput Sequencing
Published in The Journal of molecular diagnostics : JMD (01-07-2021)Get full text
Journal Article -
9
A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
Published in Clinical cancer research (01-09-2009)“…Purpose: Hans and coworkers previously developed an immunohistochemical algorithm with â¼80% concordance with the gene expression profiling (GEP)…”
Get full text
Journal Article -
10
Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B‐cell lymphoma
Published in Neuropathology (01-12-2017)“…Primary CNS diffuse large B‐cell lymphoma (PCNS‐DLBCL) and systemic DLBCL harbor mutations in MYD88 and CD79B. DNA methyltransferase (MGMT) is methylated in…”
Get full text
Journal Article -
11
Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
Published in Blood (19-04-2012)“…Mutations of the TP53 gene and dysregulation of the TP53 pathway are important in the pathogenesis of many human cancers, including lymphomas. Tumor…”
Get full text
Journal Article -
12
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice
Published in Journal of clinical oncology (20-12-2022)“…Peripheral T-cell lymphoma (PTCL) includes heterogeneous clinicopathologic entities with numerous diagnostic and treatment challenges. We previously defined…”
Get full text
Journal Article -
13
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
Published in Blood (04-02-2010)“…Peripheral T-cell lymphoma (PTCL) is often challenging to diagnose and classify. Gene expression profiling was performed on 144 cases of PTCL and natural…”
Get full text
Journal Article -
14
Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma
Published in Journal of clinical oncology (01-10-2008)“…Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like…”
Get full text
Journal Article -
15
MYC and BCL2 protein expression predicts survival in patients with diffuse large B‐cell lymphoma treated with rituximab
Published in British journal of haematology (01-05-2014)“…Summary Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous disease and “double‐hit” DLBCL, with both MYC and BCL2 translocations has a poor prognosis. In…”
Get full text
Journal Article -
16
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Published in Haematologica (Roma) (01-03-2022)“…B-cell non-Hodgkin lymphoma (B-NHL) encompasses multiple clinically and phenotypically distinct subtypes of malignancy with unique molecular etiologies. Common…”
Get full text
Journal Article -
17
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies
Published in Journal of clinical oncology (20-05-2017)“…Purpose Mantle cell lymphoma is an aggressive B-cell neoplasm that displays heterogeneous outcomes after treatment. In 2003, the Lymphoma/Leukemia Molecular…”
Get full text
Journal Article -
18
Radiologic Differentiation of Primary CNS Posttransplant Lymphoproliferative Disorder From Brain Metastasis
Published in American journal of roentgenology (1976) (01-07-2020)“…Primary CNS posttransplant lymphoproliferative disorder (PTLD) may present as multiple contrast-enhancing intraaxial lesions, often with central necrosis and…”
Get full text
Journal Article -
19
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
Published in Blood (15-09-2022)“…Peripheral T-cell lymphomas (PTCLs) are heterogenous T-cell neoplasms often associated with epigenetic dysregulation. We investigated de novo DNA…”
Get full text
Journal Article -
20
Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Published in Journal of clinical oncology (20-12-2013)“…We previously reported that constitutive STAT3 activation is a prominent feature of the activated B-cell subtype of diffuse large B-cell lymphomas (ABC-DLBCL)…”
Get full text
Journal Article